McKesson price target raised to $1,050 from $960 at Barclays

Barclays raised the firm’s price target on McKesson (MCK) to $1,050 from $960 and keeps an Overweight rating on the shares. The firm expects the stock to “remain in favor” as investors seek “pockets of safety within healthcare,” but notes McKesson is now trading at a 15% premium to its three-year average.